Lecap Asset Management Ltd. Increases Stake in Medical Properties Trust, Inc. (NYSE:MPW)

Lecap Asset Management Ltd. increased its position in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 150.9% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 276,317 shares of the real estate investment trust's stock after purchasing an additional 166,182 shares during the period. Lecap Asset Management Ltd.'s holdings in Medical Properties Trust were worth $1,616,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in MPW. Everence Capital Management Inc. acquired a new position in Medical Properties Trust in the third quarter valued at $587,000. TriaGen Wealth Management LLC acquired a new position in Medical Properties Trust in the 3rd quarter valued at about $335,000. Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in Medical Properties Trust by 14.6% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 111,807 shares of the real estate investment trust's stock valued at $654,000 after acquiring an additional 14,219 shares during the last quarter. Regent Peak Wealth Advisors LLC acquired a new stake in Medical Properties Trust during the 3rd quarter worth approximately $125,000. Finally, Future Financial Wealth Managment LLC purchased a new position in shares of Medical Properties Trust in the 3rd quarter valued at approximately $29,000. 71.79% of the stock is owned by institutional investors and hedge funds.

Medical Properties Trust Price Performance

Shares of MPW traded up $0.23 during trading hours on Thursday, reaching $4.95. The company had a trading volume of 12,339,489 shares, compared to its average volume of 17,246,941. The company has a current ratio of 2.93, a quick ratio of 2.93 and a debt-to-equity ratio of 1.51. Medical Properties Trust, Inc. has a 12-month low of $2.92 and a 12-month high of $6.55. The firm has a 50 day simple moving average of $5.15 and a 200-day simple moving average of $4.90. The company has a market capitalization of $2.97 billion, a price-to-earnings ratio of -2.23, a PEG ratio of 0.76 and a beta of 1.29.

Medical Properties Trust (NYSE:MPW - Get Free Report) last issued its earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.21 by ($0.75). The business had revenue of $266.60 million for the quarter, compared to the consensus estimate of $259.53 million. The company's quarterly revenue was down 21.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.48 earnings per share. Research analysts expect that Medical Properties Trust, Inc. will post 0.85 earnings per share for the current year.

Medical Properties Trust Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 10th. Shareholders of record on Monday, September 9th were given a dividend of $0.08 per share. The ex-dividend date was Monday, September 9th. This represents a $0.32 dividend on an annualized basis and a yield of 6.47%. Medical Properties Trust's payout ratio is -14.41%.

Insider Buying and Selling at Medical Properties Trust

In other news, Director Michael G. Stewart sold 32,780 shares of Medical Properties Trust stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $5.46, for a total transaction of $178,978.80. Following the completion of the transaction, the director now owns 221,245 shares of the company's stock, valued at $1,207,997.70. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, Director Michael G. Stewart sold 32,780 shares of the stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $5.46, for a total value of $178,978.80. Following the sale, the director now directly owns 221,245 shares in the company, valued at $1,207,997.70. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director C Reynolds Thompson III sold 20,530 shares of Medical Properties Trust stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total value of $89,921.40. Following the transaction, the director now owns 54,637 shares of the company's stock, valued at $239,310.06. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 63,335 shares of company stock valued at $318,825. Insiders own 1.53% of the company's stock.

Analysts Set New Price Targets

MPW has been the subject of several recent research reports. BNP Paribas downgraded Medical Properties Trust from an "outperform" rating to a "neutral" rating and decreased their price target for the stock from $6.00 to $4.00 in a report on Tuesday, July 2nd. Wolfe Research upgraded shares of Medical Properties Trust to a "hold" rating in a research report on Monday, September 23rd. Truist Financial lifted their target price on shares of Medical Properties Trust from $5.00 to $6.00 and gave the company a "hold" rating in a report on Friday, September 13th. Finally, Colliers Securities upgraded shares of Medical Properties Trust from a "neutral" rating to a "buy" rating and set a $6.50 price target on the stock in a research note on Friday, September 13th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $5.38.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.